Bottom line
APDJX vs EFA: the short answer
APDJX (Artisan International Small-Mid Fund) and EFA (iShares MSCI EAFE ETF) are both mutual funds.
But EFA is far broader, holding 691 positions to 121 for APDJX, so beyond the top names it adds exposure APDJX doesn't have.
EFA is cheaper at 0.32% vs 1.16% — a difference of $84 a year per $10,000 invested.
Over five years, EFA returned +4.7% a year vs +0.8% for APDJX (reporting dates differ).
Updated Nov 19, 2026
APDJX vs EFA side by side
| APDJX | EFA | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Artisan Partners | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 1.16% | 0.32% |
| Annual cost per $10k | $116 | $32 |
| 10-yr cost on $10k (prospectus) | $1,409 | $406 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +18.5% | +3.4% |
| 5-yr return (annualized) | +0.8% | +4.7% |
| 10-yr return (annualized) | — | +5.1% |
| Best quarter | — | +18.1% |
| Worst quarter | — | −22.9% |
| Net assets (fund) | $2.5B | $78.0B |
| Number of holdings | 121 | 691 |
| Portfolio turnover | 34% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
APDJX and EFA share none of their top holdings.
APDJX top 10
- LivaNova plc — 4.45%
- Metso Oyj — 3.79%
- Genmab A/S — 2.99%
- Brenntag SE — 2.50%
- Nice Ltd. — 2.40%
- Omron Corp. — 2.37%
- Kinaxis, Inc. — 2.24%
- Convatec Group plc — 2.14%
- Glanbia plc — 2.07%
- Money Forward, Inc. — 1.91%
EFA top 10
- ASML Holding N.V. — 2.90%
- Hsbc Holdings Plc — 1.66%
- Roche Holding AG — 1.39%
- Novartis AG — 1.30%
- Nestle S.A. — 1.17%
- Shell Plc — 1.17%
- Astrazeneca Plc — 1.17%
- Siemens Aktiengesellschaft — 1.10%
- Mitsubishi UFJ Financial Group, Inc. — 1.08%
- Bhp Group Limited — 0.97%
FAQ
What is the difference between APDJX and EFA?
Which is cheaper, APDJX or EFA?
Should I own both APDJX and EFA?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.